Ascentage Pharma is the latest mainland biotech company to choose Hong Kong for IPO

Hong Kong also faces rising competition from Shanghai. WuXi AppTec, the leading mainland biotech company that privatised in New York two years ago, has been given the green light to relist on the A-share market through an IPO in Shanghai, just seven weeks …
( read original story …)


Related Post